Stifel Financial Corp Rhythm Pharmaceuticals, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 19,842 shares of RYTM stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,842

Previous 28,058 29.28%

Holding current value

$1.12 Million

Previous $1.15 Million 9.81%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.81 - $55.0 $335,294 - $451,880	-8,216 Reduced 29.28%	19,842 $1.04 Million
Q2 2024 Aug 13, 2024	BUY	$35.41 - $44.37 $4,284 - $5,368	121 Added 0.43%	28,058 $1.15 Million
Q1 2024 May 13, 2024	SELL	$39.12 - $52.44 $105,154 - $140,958	-2,688 Reduced 8.78%	27,937 $1.21 Million
Q4 2023 Feb 12, 2024	SELL	$21.39 - $49.64 $328,657 - $762,718	-15,365 Reduced 33.41%	30,625 $1.41 Million
Q3 2023 Nov 13, 2023	SELL	$15.81 - $27.8 $11,161 - $19,626	-706 Reduced 1.51%	45,990 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $411,361 - $533,106	25,206 Added 117.29%	46,696 $770,000
Q1 2023 May 12, 2023	BUY	$16.88 - $34.24 $35,616 - $72,246	2,110 Added 10.89%	21,490 $383,000
Q4 2022 Feb 13, 2023	SELL	$22.21 - $30.25 $4,442 - $6,050	-200 Reduced 1.02%	19,380 $564,000
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $2,661 - $19,096	619 Added 3.26%	19,580 $480,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $23,103 - $90,711	-7,405 Reduced 28.09%	18,961 $79,000
Q1 2022 May 13, 2022	SELL	$6.13 - $12.24 $291,463 - $581,975	-47,547 Reduced 64.33%	26,366 $303,000
Q4 2021 Feb 14, 2022	SELL	$8.62 - $13.9 $523,001 - $843,354	-60,673 Reduced 45.08%	73,913 $738,000
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $546,951 - $970,276	-46,828 Reduced 25.81%	134,586 $1.76 Million
Q2 2021 Aug 13, 2021	BUY	$18.52 - $22.55 $1.19 Million - $1.45 Million	64,181 Added 54.75%	181,414 $3.55 Million
Q1 2021 May 14, 2021	BUY	$20.25 - $39.49 $2.14 Million - $4.17 Million	105,579 Added 905.95%	117,233 $2.49 Million
Q4 2020 Feb 12, 2021	BUY	$21.17 - $32.61 $246,715 - $380,036	11,654 New	11,654 $347,000
Q3 2018 Nov 13, 2018	SELL	$26.99 - $35.85 $230,440 - $306,087	-8,538 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $145,316 - $300,537	8,538 New	8,538 $266,000

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Rhythm Pharmaceuticals, Inc. Transaction History